Insider Transaction Report for Arcus Biosciences, Inc.

Yasunori Kaneko, a director at Arcus Biosciences, Inc. (RCUS), reported a transaction on June 11, 2026. The transaction involved the acquisition of 5,700 shares of Common Stock, indicated by transaction code "A". Following this transaction, Kaneko holds 25,700 shares directly. Additionally, Kaneko has indirect ownership of 252,524 shares through Kaneko Investments, LLC, 505,050 shares through Kaneko Capital, LLC, and 174,681 shares through a trust. The filing also notes the grant of 16,900 stock options with an exercise price of $23.30, vesting on June 11, 2027, or earlier upon a change in control. Some RSUs previously reported vested on June 11, 2026, and were transferred to a trust.